This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007 Apr;14(4):e11.

doi: 10.1111/j.1468-1331.2007.01683.x.

The protein load of therapeutic botulinum toxins

A Pickett, R O'Keeffe, N Panjwani

PMID: 17388970
DOI: 10.1111/j.1468-1331.2007.01683.x

Review

The protein load of therapeutic botulinum toxins

A Pickett et al. Eur J Neurol. 2007 Apr.

. 2007 Apr;14(4):e11.

doi: 10.1111/j.1468-1331.2007.01683.x.

Authors

A Pickett, R O'Keeffe, N Panjwani

PMID: 17388970
DOI: 10.1111/j.1468-1331.2007.01683.x

No abstract available

PubMed Disclaimer

Similar articles

Botulinum toxin A: is it really that fragile a molecule?
Shome D, Nair AG, Kapoor R, Jain V. Shome D, et al. Dermatol Surg. 2010 Dec;36 Suppl 4:2106-10. doi: 10.1111/j.1524-4725.2010.01702.x. Dermatol Surg. 2010. PMID: 21134042
Differentiating toxins on new turf.
Sagrillo DP. Sagrillo DP. Plast Surg Nurs. 2011 Jan-Mar;31(1):36-8. doi: 10.1097/PSN.0b013e3182090852. Plast Surg Nurs. 2011. PMID: 21368647 No abstract available.
IncobotulinumtoxinA in esthetics.
Kerscher M, Yutskovskaya Y, Flynn TC. Kerscher M, et al. J Drugs Dermatol. 2013 Jun 1;12(6):e111-20. J Drugs Dermatol. 2013. PMID: 23839200 Review.
Comparing two botulinum toxin type A formulations using manufacturers' product summaries.
Wenzel R, Jones D, Borrego JA. Wenzel R, et al. J Clin Pharm Ther. 2007 Aug;32(4):387-402. doi: 10.1111/j.1365-2710.2007.00835.x. J Clin Pharm Ther. 2007. PMID: 17635341
Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A.
Mannava S, Plate JF, Stone AV, Smith TL, Smith BP, Koman LA, Tuohy CJ. Mannava S, et al. J Hand Surg Am. 2011 Oct;36(10):1708-10. doi: 10.1016/j.jhsa.2011.07.011. Epub 2011 Sep 8. J Hand Surg Am. 2011. PMID: 21903346 Review. No abstract available.

See all similar articles

Cited by

Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial.
Campanati A, Giuliodori K, Martina E, Giuliano A, Ganzetti G, Offidani A. Campanati A, et al. J Neural Transm (Vienna). 2014 Jan;121(1):21-6. doi: 10.1007/s00702-013-1074-1. Epub 2013 Sep 20. J Neural Transm (Vienna). 2014. PMID: 24052109 Clinical Trial.
Immunogenicity of botulinum toxins.
Naumann M, Boo LM, Ackerman AH, Gallagher CJ. Naumann M, et al. J Neural Transm (Vienna). 2013 Feb;120(2):275-90. doi: 10.1007/s00702-012-0893-9. Epub 2012 Sep 25. J Neural Transm (Vienna). 2013. PMID: 23008029 Free PMC article. Review.
Botulinum Toxin in Aesthetic Medicine: Myths and Realities.
Dover JS, Monheit G, Greener M, Pickett A. Dover JS, et al. Dermatol Surg. 2018 Feb;44(2):249-260. doi: 10.1097/DSS.0000000000001277. Dermatol Surg. 2018. PMID: 29016535 Free PMC article. Review.
AbobotulinumtoxinA: A 25-Year History.
Monheit GD, Pickett A. Monheit GD, et al. Aesthet Surg J. 2017 May 1;37(suppl_1):S4-S11. doi: 10.1093/asj/sjw284. Aesthet Surg J. 2017. PMID: 28388718 Free PMC article. Review.
[Botulinum toxin in dermatology].
Philipp-Dormston WG. Philipp-Dormston WG. Hautarzt. 2014 Feb;65(2):133-43; quiz 144-5. doi: 10.1007/s00105-013-2744-5. Hautarzt. 2014. PMID: 24549483 German.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information